Patents by Inventor Erez EITAN

Erez EITAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment and diagnosis of parkinson's disease using isolated and enriched populations of biofluid-derived extracellular vesicles
    Patent number: 11899024
    Abstract: The invention relates generally to a process for isolating subpopulations of EVs to identify biomarkers useful identifying, determining the progression of, and/or prognosing a disease, including a neurological disease. More particularly, the present invention relates to detection technology of various exosomal biomarkers including proteins, protein modifications, sugars, RNA, DNA, lipids, and metabolites, and combinations thereof.
    Type: Grant
    Filed: July 12, 2018
    Date of Patent: February 13, 2024
    Assignee: Exosome Diagnostics, Inc.
    Inventors: Mia Sher, Erez Eitan, Christine Coticchia, Johan Karl Olov Skog, Robert Kitchen, Seth Yu
  • DIAGNOSTIC ASSAYS EMPLOYING NEURON-DERIVED EXOSOMES
    Publication number: 20230417773
    Abstract: The present invention relates to minimally invasive, biomarker-based diagnostics for neurodegenerative diseases, and to compositions and methods for isolating and analyzing specific populations of extracellular vesicles (EV). In particular, embodiments of the invention relate to methods and systems for isolating, identifying or capturing neuron-derived EV, for analyzing biological samples, and for diagnosing, assessing and predicting the development of neurological and neurodegenerative conditions.
    Type: Application
    Filed: September 14, 2021
    Publication date: December 28, 2023
    Inventor: Erez Eitan
  • METHODS FOR ISOLATING AND ENRICHING POPULATIONS OF BIOFLUID-DERIVED EXTRACELLULAR VESICLES, AND METHODS OF USE THEREOF
    Publication number: 20200292561
    Abstract: The invention relates generally to a process for isolating subpopulations of EVs to identify biomarkers useful identifying, determining the progression of, and/or prognosing a disease, including a neurological disease. More particularly, the present invention relates to detection technology of various exosomal biomarkers including proteins, protein modifications, sugars, RNA, DNA, lipids, and metabolites, and combinations thereof.
    Type: Application
    Filed: July 12, 2018
    Publication date: September 17, 2020
    Applicant: Exosome Diagnostics, Inc.
    Inventors: Mia SHER, Erez EITAN, Christine COTICCHIA, Johan Karl Olov SKOG, Robert KITCHEN, Seth YU